# Dianthus Therapeutics, Inc.: Form 8-K, filed Jun 25, 2018

- Company: [Dianthus Therapeutics, Inc.](/companies/dnth.md) (CIK 1690585)
- Form: 8-K
- Filed: 2018-06-25
- Accepted by EDGAR: Jun 25, 2018, 16:49 ET
- Period: 2018-06-20
- Accession: 0001193125-18-202570
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1690585/000119312518202570/d835168d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1690585/000119312518202570/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1690585/000119312518202570/d835168d8k.htm

Filed Jun 25, 2018.
Source: SEC EDGAR, the filing index for accession 0001193125-18-202570. Last ingested by Listed: Nov 13, 2026, 16:49 ET. No prices; not investment advice.
